Clinical Trial Update: QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed [Phase 1, Phase 2]

View source ↗

Summary

This update reports the termination of the Phase 1/2 QUILT-3.090 NANT squamous cell carcinoma vaccine trial in patients with progressed disease, with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma

Drugs mentioned

• QUILT-3.090 NANT SCC Vaccine (NANT Squamous Cell Carcinoma Vaccine)

Snippet

Sponsor: ImmunityBio, Inc. | Conditions: Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-08-05